Bartlett & Co. LLC Acquires 7,396 Shares of iShares NASDAQ Biotechnology Index (IBB)

Bartlett & Co. LLC increased its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 11,094 shares of the financial services provider’s stock after purchasing an additional 7,396 shares during the period. Bartlett & Co. LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $1,185,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. CHURCHILL MANAGEMENT Corp increased its stake in iShares NASDAQ Biotechnology Index by 223.2% during the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 1,801,330 shares of the financial services provider’s stock worth $192,328,000 after buying an additional 1,244,066 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its holdings in iShares NASDAQ Biotechnology Index by 175.5% during the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 635,875 shares of the financial services provider’s stock worth $212,132,000 after acquiring an additional 405,091 shares in the last quarter. Lockheed Martin Investment Management Co. grew its holdings in iShares NASDAQ Biotechnology Index by 200.0% during the 4th quarter. Lockheed Martin Investment Management Co. now owns 329,400 shares of the financial services provider’s stock worth $35,170,000 after acquiring an additional 219,600 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in iShares NASDAQ Biotechnology Index by 9.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 101,917 shares of the financial services provider’s stock worth $33,991,000 after acquiring an additional 8,667 shares in the last quarter. Finally, Valicenti Advisory Services Inc. grew its holdings in iShares NASDAQ Biotechnology Index by 199.2% during the 4th quarter. Valicenti Advisory Services Inc. now owns 95,748 shares of the financial services provider’s stock worth $10,223,000 after acquiring an additional 63,746 shares in the last quarter. 21.23% of the stock is currently owned by hedge funds and other institutional investors.

iShares NASDAQ Biotechnology Index (NASDAQ IBB) opened at $112.00 on Friday. iShares NASDAQ Biotechnology Index has a twelve month low of $88.96 and a twelve month high of $114.17. The company has a market cap of $10,460.00, a P/E ratio of 3.70 and a beta of 1.38.

The company also recently declared a quarterly dividend, which was paid on Thursday, December 28th. Shareholders of record on Friday, December 22nd were issued a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend was Thursday, December 21st. This is a boost from iShares NASDAQ Biotechnology Index’s previous quarterly dividend of $0.04. iShares NASDAQ Biotechnology Index’s payout ratio is 2.38%.

TRADEMARK VIOLATION NOTICE: “Bartlett & Co. LLC Acquires 7,396 Shares of iShares NASDAQ Biotechnology Index (IBB)” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3146929/bartlett-co-llc-acquires-7396-shares-of-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.